BRCA2 Antibody (5F6)

BRCA2-5F6 recognizes the BRCA2 gene product, a 390kDa nuclear protein. The BRCA2 gene was originally isolated based on its importance in the predisposition of women to early-onset breast and ovarian cancers, suggesting mutations affect its tumor suppressor-like activity. Targeted disruption of the BRCA2 gene in mice and binding of Rad51 to its carboxyl terminus have indicated an involvement in DNA recombination and double strand break repair.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: IF/IHC.

Showing Publications 1 - 2 of 2.

Publications using NBP1-41189	Applications	Species
Bernard-Gallon DJ, Dechelotte PJ, Le Corre L et al. Differential expressions of BRCA1 and BRCA2 in infantile gynecomastia. Anticancer Res 2004-01-01 [PMID: 15015615] (IF/IHC, Human)	IF/IHC	Human
Bernard-Gallon DJ, Dechelotte P, Vissac C et al. BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite. Breast Cancer Res 2001-01-01 [PMID: 11250747] (IF/IHC, Human)	IF/IHC	Human

Array NBP1-41189

• BRCA2 Antibodies
• BRCA2 ELISA Kit
• BRCA2 Proteins